AgingResearch.NewsJoin free

Bio-Thera Solutions

CompanyChina

Bio-Thera Solutions develops one asset, in phase 1 (BAT5906 in age-related macular degeneration). Mostly antibody acting on VEGFA; based in China.

1
Asset
Furthest stage
Phase 1
5
Trials
1
Signal

Pipeline

1

  • BAT5906

    Neutralizes VEGF-A to inhibit abnormal blood vessel growth and vascular leakage in the retina.

    Phase 1, Antibody, VEGFA, age-related macular degeneration

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials5
  • Signals1
  • Similar companies6

Intelligence